comparemela.com

Latest Breaking News On - இத்தாலிய இரசாயன சமூகம் - Page 1 : comparemela.com

Production of Phytotoxic Metabolites by Botryosphaeriaceae in Naturally Infected and Artificially Inoculated Grapevines – Science & Wine

By Pierluigi Reveglia, Antonio Evidente, Alessio Cimmino, Marco Masi, Jennifer Millera Niem,Regina  Billones-Baaijens, Sandra Savocchia Grapevine trunk diseases (GTDs) represent a serious threat to vineyards worldwide causing substantial economic and yield losses. To date, no curative methods are available and the connection between pathogen and symptom expression is not completely understood [ 1]. Among the GTDs, Botryosphaeria dieback (BD) is considered a serious problem worldwide causing cankers, dieback and eventually death of vines. At least 27 species of Botryosphaeriaceae are associated with BD, although only 11 species have been reported in Australian vineyards to date [ 1]. In Europe, the disease is also associated with foliar symptoms, although these symptoms have not been reported in Australian vineyards [

Skye Bioscience Appoints Cannabinoid Science Experts Giovanni Appendino, PhD and Eduardo Muñoz,

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Skye Bioscience Appoints Cannabinoid Science Experts Giovanni Appendino, PhD and Eduardo Muñoz, . Skye Bioscience, Inc.March 8, 2021 GMT San Diego, Calif., March 08, 2021 (GLOBE NEWSWIRE) Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, announced today the appointment of scientific innovators and cannabinoid experts, Giovanni Appendino, PhD and Eduardo Muñoz, MD, PhD to its scientific advisory board. “We are honored to welcome two of the world’s most influential thought leaders in cannabinoid science, Drs. Appendino and Muñoz, to our scientific advisory board as we continue to advance our research and deepen our understanding of cannabinoid-based medicines,” said Punit Dhillon, Chief Exec

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.